New York, Sep 15 (IANS) A combination of drugs can help reduce symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, according to a new study.
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, compared with haloperidol alone, according to the study led by researchers at The University of Texas MD Anderson Cancer Center.
David Hui, professor of Palliative, Rehabilitation and Integrative Medicine, said that advanced delirium is common and highly distressing in many patients with advanced cancers receiving palliative care.
“But we’ve had limited evidence on the use and effectiveness of treatment for this condition,” said Hui.
“The RECORD trial offers valuable data and insights that support the use of therapy in the palliative care setting in order to provide patients with greater comfort,” he added.
Agitated delirium occurs when a patient’s brain function begins to deteriorate as their cancer advances, resulting in many patients beginning to behave aggressively or abnormally.
Although the use of medication in this setting has been debated, these results suggest tailored combination treatments can significantly improve symptoms for patients at the end of life.
In the study, patients that received the combination of haloperidol and lorazepam experienced a significant decrease in agitated delirium when measured at 24 hours with a standard scoring tool.
In that same time frame, this group needed no more than two rescue doses, or additional medication provided as needed.
The team also observed a significant decrease in agitated delirium in patients treated with lorazepam alone, but these patients required more rescue doses.
The placebo group saw very little reduction in delirium, and, in some scenarios, patients needed as many as five rescue doses.
“By proactively personalising treatment of this distressing symptom, we are providing caregivers, families and patients an opportunity for meaningful connection in the time they have remaining,” Hui said.
–IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
